The 340B Drug Discount Program was designed to help safety-net providers make drugs available to low-income patients and earn revenue. Drug manufacturers have put restrictions on which pharmacies ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...
The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.
In just 10 years, annual 340B purchases grew more than 700%, from $7.5 billion in 2013 to $53.7 billion in 2022. Factors underlying this growth include. Exponential growth in participation by non ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Proximity, a Chicago startup helping health care ...
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional ...
Hospitals and other 340B entities purchased more than $66 billion in covered outpatient drugs under the program in 2023, according to HRSA. Critics of the program have said it is rife with ...
Cutting corners: Researchers at Imperial College London say an artificial intelligence-based science tool created by Google needed just 48 hours to solve a problem that took them roughly a decade ...
The landing page revealed the As Ever logo, which PEOPLE understands is a tribute to Prince Harry. The logo incorporates a palm tree as a nod to the Duke and Duchess’s home in California ...
Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis are seeking to block a major hospital trade group from intervening in court cases over their proposed … ...
However, managing a 340B program is complex and time consuming given the requirement to maintain compliance. Participating providers struggle to verify patient eligibility, implement robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback